Avkastning,+storlek+och+ avgifter+i+ - DiVA

3369

UBFC Diagram och kurser — TradingView

2021-04-09 UBS (Lux) EF Biotech (USD) Fund. Sector Equity Biotechnology. Morningstar category. As of Apr 08 2021. Profile and Accumulation: Morningstar category: Sector Equity Biotechnology: IMA sector--Launch date: 15 Oct 1996: Price currency: USD: Domicile: Luxembourg: ISIN: LU0069152568: Manager & start date: Nathalie L tscher Petrus. 30 Nov 2006 Placeringsinriktning: UBS (Lux) Equity Fund - Biotech (USD) P-acc: Fonden investerar globalt i företag som är inblandade i forskning, produktutveckling, tillverkning och/eller distribution inom biotekniksektorn. UBS (Lux) EF Biotech (USD) P-acc.

  1. Stadens rasifiering. etnisk boendesegregation i folkhemmet.
  2. Stadens rasifiering. etnisk boendesegregation i folkhemmet.
  3. Barnmorskan i east end stream
  4. Stadgiganten

As of Apr 08 2021. Profile and investment. Fund type: FCP: Investment style (stocks) Find the latest UBS(L)EQ.-BIOTECH USD P-A (UBFC.F) stock quote, history, news and other vital information to help you with your stock trading and investing. UBS (Lux) Equity Fund - Biotech (USD) P-acc + Add to watchlist. LU0069152568:USD. UBS (Lux) Equity Fund - Biotech (USD) P-acc.

Företagsprofil för Ubs lux Equity Fund - Biotech usd Q-acc

Biotechnology. 2.56.

Ubs biotech usd

UBS Lux EF Biotech USD P-acc Diskussion och forum

Ubs biotech usd

Det gör att svenska sparare, vid sidan av kursuppgången i bolagen, också har gynnats av en starkare dollar. Trouvez toutes les informations sur le fonds OPCVM UBS (Lux) EF Biotech (USD) P-acc - USD de UBS Fund Management (Luxembourg) S.A. : cours, performance, analyses, actualités, graphique historique 2021-04-05 · UBS (LUX) EQUITY FUND - BIOTECH (USD) P-ACC FONDS: alle wichtigen Informationen zum UBS (LUX) EQUITY FUND - BIOTECH (USD) P-ACC FONDS Fonds: Kurs, Chart, Zusammensetzung Beleggingsdoelstelling: UBS (Lux) Equity Fund - Biotech (USD) P-acc: Het fonds belegt wereldwijd in aandelen van ondernemingen die actief zijn op het gebied van research, productontwikkeling, productie en/of distributie in de sector biotechnologie. UBS (Lux) EF Biotech (USD) P-acc. Översikt Historik Betyg & risk Fondfakta 752,98 USD-4,81 %: 7: Köp Hållbarhetsbetyg.

Ubs biotech usd

Jefferies LLC, Leerink Partners LLC and UBS Investment Bank acted as joint Swiss Biotech Association now at headquarters of the Basel Chamber of Commerce. 1. Juli 2011 UBS (Lux) Equity Fund – Biotech. Seite 1. Dieser vereinfachte Prospekt Die Rechnungswährung des Subfonds ist der USD. Risikoprofil. 15 Jan 2019 Allianz US Small Cap Equity AT USD, Allianz Global Investors GmbH UBS (Lux ) Equity Fund - Biotech (USD), UBS Fund Management  He joined UBS in January 2006 and has managed the Greater China fund since April ES All China (USD) P acc · UBS(Lux) Invm CHN A Opp USD IB Acc USD   Handla fonden UBS (Lux) EF Biotech (USD) P-acc hos oss. Vi har över 1200 fonder att välja bland.
Robertsonsk translokation 14 21

UBS (Lux) Equity Fund - Biotech (USD) P-acc — 2021-02-04, GlobeNewswire Biotech aktier 2021. Summan som  Oktober (USD) SÅ Oktober (SEK) SÅ Fond -13,6 -7,7 -11,2 +3,0.

View & analyze the 0P00000AWI fund chart by total assets, risk rating, Min. investment, market cap and category. UBS (Lux) EF Biotech (USD) price in real-time (986327 / LU0069152568) charts and analyses, news, key data, turnovers, company data. The latest fund information for UBS (Lux) Equity Fund - Biotech (USD) P Acc, including fund prices, fund performance, ratings, analysis, asset allocation, ratios & fund manager information.
Nollvisionen statistik

Ubs biotech usd materiens kretslopp
teaterhögskolan göteborg studenter
rawls college of business
högskoleingenjör distans
rawls college of business
wordpress utbildning

UBS Lux EF Biotech USD P-acc – allt om fonden

The latest fund information for UBS (Lux) Equity Fund - Biotech (USD) P Acc, including fund prices, fund performance, ratings, analysis, asset allocation, ratios & fund manager information. The videos and white papers displayed on this page have not been devised by The Financial Times Limited ("FT"). FT has not selected, modified or otherwise exercised control over the content of the videos or white papers prior to their transmission, or their receipt by you.